122 Letters in Drug Design & Discovery, 2010, 7, 122-127
Synthesis and Biological Evaluation of Capsaicin Derivatives as Analgesia Drugs
Hai Qian1, Zhixian Fu1, Huibin Zhang1, Jinpei Zhou*,2, Wenlong Huang*,1, Jing Jin1, Wei Chen1 and Dongyan Dai1
12
Center of Drug Discovery, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China
Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China
Received August 17, 2009: Revised October 20, 2009: Accepted October 20, 2009
Abstract: TRPV1 is an important analgesia target. Capsaicin, the prototypical TRPV1 agonist, has a clear therapeutic potential. But the highly pungency limited its use. In this letter, for lowering its pungency, a series of capsaicin derivatives were designed and synthesized, including 10 compounds which were the direct combination of capsaicin and dihydro capsaicin with various NSAIDs. Preliminary bio-logical tests suggested that some compounds had both anti-inflammatory activity and analgesic activity and their pungency was lower. Based on these results, some of these molecules can be considered as lead candidates for the further development of analgesic drugs.
Keywords: Analgesia Drugs, Capsaicin Derivatives, TRPV1 Agonist. INTRODUCTION
Pain, especially chronic pain, is a persistent trouble to human health. Currently, due to its complicated pathological mechanism, all marketed drugs against pain have their deficiencies [1]. There-fore, it has always been one of the main targets to seek analgesic drugs with high potency and low toxicity [2].
In recent years, some progress has been made in the research on receptors and their selective ligand responsible for pain conduction [3]. In 1997, the transient receptor potential vanilloid subtype 1 (TRPV1) receptor, the cellular target of capsaicin, was cloned and characterized [4]. It is a non-selective cation channel expressed in primary sensory neurons, and is a key pain sensor and integrator. TRPV1 has been shown to be important in both nociception and the inflammatory response, and hence has rapidly become a significant therapeutic target [5].
Capsaicin, the prototypical TRPV1 agonist, which was best recognized as the pungent ingredient in hot chili peppers, has a clear therapeutic potential [6]. Capsaicin-containing creams have been in clinical use for decades for indications like diabetic neu-ropathy. Though the highly pungency limited its use, capsaicin has great value for further research.
In this letter, according to the molecular structure of capsaicin, intended for lowering its pungency, a series of capsaicin derivatives were designed. Capsaicin and dihydro capsaicin (Fig. (1)) were combined with the pharmacophore of non-steroidal anti-inflammatory drugs (NSAIDs), to form a new class of potent TRPV1 agonist. As a result, 10 capsaicin derivatives were synthe-sized and their activities were evaluated.
H3


H3


RESULTS AND DISCUSSION Synthesis
We designed and synthesized a series of capsaicin derivatives, including 10 compounds which were the direct combination of capsaicin and dihydro capsaicin with various NSAIDs. The target compounds were shown in the Table 1. Biological Activity
The new compounds were tested for TRPV1 agonist activity, pungency, anti-inflammatory activity and analgesic activity. The results of primary pharmacological test are as followed: In the TRPV1 agonist high throughput screening model (Table 2), all the compounds enhance Ca2+ inflow, among which compound A8, A10 show better than capsaicin. The pungent potency of all the com-pounds is lower than capsaicin in the wiping test (Table 3). In the model of xylene-inducing mice auricle swelling (Table 4), A1, A2, A6, A8 and A10 have anti-inflammatory effect. In the model of mouse acetic acid writhing test (Table 5), compound A4, A6, A7, A8 and A10 can significantly inhibit mouse’s writhing reaction, which means that the compounds have potent analgesic activity. EXPERIMENTAL SECTION
All reagents were of commercial quality and were used as re-ceived. Solvents were dried and purified by using standard tech-niques. Reactions were monitored by TLC. Melting points were uncorrected. 1H NMR spectra were recorded on a Brucker ACF-300 MHz spectrometer with TMS as the internal standard in CDCl3. Mass Spectra were made with HP1100 analyzer. Element analyses were performed on Carlo Erba 1106 instrument. General Procedure for the Preparation of A1-A10
Capsaicin or dihydro capsaicin 0.30g (0.98mmol), DMAP 0.01g (0.08mmol), DCC 0.30g (1.46mmol) and different NSAIDs (1.10mmol), dissolved in 35ml dry CH2Cl2, The mixture was stirred at 30-35 C for 6-8 h. The reaction was monitored by TLC and filtrated. The filtrate was concentrated under reduced pressure to give a residue which was partitioned between ethyl acetate and water. The ethyl acetate extract was washed with saturated brine, dried over Na2SO4. After evaporation of solvent, the crude product was subjected to silica gel column, and chromatographed with elu-ent (ethyl acetate/ hexane 1:2) to yield the desired product.
© 2010 Bentham Science Publishers Ltd.
Fig. (1). Structure of capsaicin and dihydro capsaicin.
*Address correspondence to these authors at the Center of Drug Discovery, China Pharmaceutical University, Nanjing 210009, People’s Republic of China; Tel: +86-(0)25-85230904; Fax: +86-(0)25-83271480; E-mail: jpzhou668@163.com Tel: +86-(0)25-83271480; Fax: +86-(0)25-83271480; E-mail: ydhuangwenlong@126.com
1570-1808/10 $55.00+.00
76-81 Synthesis and Biological Evaluation of Nitric Oxide-releasing Derivatives of Capsaicin as Analgesia Drugs Liang Ge, jingjie Wang#, Xiaoyan Zhang, Huibi...
热门文档